What are the useful examinations for exposed, asymptomatic children having positive intradermal reactions to tuberculin and normal thoracic x-rays?;Quels sont les examens utiles devant un enfant exposé, asymptomatique ayant une intra-dermo réaction à la tuberculine (IDR) positive et une radiographie thoracique normale?

Revue des Maladies Respiratoires

Volumn 21, Issue 3 II, 2004, Pages

  Delacourt, C ^a   Albertini, M ^b   Decludt, B ^c   Scheinmann, P ^d   Marguet, C ^e  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BCG VACCINATION; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; ENZYME LINKED IMMUNOSPOT ASSAY; FRANCE; HUMAN; HYPERURICEMIA; LIVER TOXICITY; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 3242805120     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Jasmer RM, Nahid P, Hopewell PC: Clinical practice: Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-6.
2. Commission de transparence: Tuberrest. AFSSAPS 2003: 1-7.
3. Huebner RE, Schein MF, Bass JB Jr: The tuberculin skin test. Clin Infect Dis 1993; 17: 968-75.
4. Menzies R: Tuberculin skin testing. In: Reichman L, Hershfield E, Eds. Tuberculosis, a comprehensive international approach. Marcel Dekker, New York. 2000: 279-322.
5. Schuit KE: Miliary tuberculosis in children: Clinical and laboratory manifestation in 19 patients. Am J Dis Child 1979; 133: 583-5.
6. Starke JR, Taylor-Watts KT: Tuberculosis in the pediatric population of Houston, Texas. Pediatrics 1989; 84: 28-35.
7. Vallejo JG, Ong LT, Starke JR: Clinical features, diagnosis, and treatment of tuberculosis in infants. Pediatrics 1994; 94: 1-7.
8. American Thoracic Society, Centers for Disease Control and Prevention: Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 2000; 161: 1376-95.
9. Singh D, Sutton C, Woodcock A: Repeat tuberculin testing in BCG-vaccinated subjects in the United Kingdom. The booster effect varies with the time of reading. Am J Respir Crit Care Med 2001; 164: 962-4.
10. American Thoracic Society, Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-47.
11. Menzies R, Vissandjee B: Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-5.
12. Delacourt C: Tuberculose pulmonaire de l'enfant. Rev Prat 1996; 10: 33-8.
13. Ministère de la santé de la famille et des personnes handicapées, Direction générale de la Santé. Avis du conseil supérieur d'hygiène publique de France, section maladies transmissibles, relatif au traitement de la Tuberculose-infection. http://www.sante.gouv.fr/htm/dossiers/hygiene/tuberc_infect.pdf 2003.
14. Lockman S, Tappero JW, Kenyon TA, Rumisha D, Huebner RE, Binkin NJ: Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis 1999; 3: 23-30.
15. Cohn DL: The effect of BCG vaccination on tuberculin skin testing. Does it matter? Am J Respir Crit Care Med 2001; 164: 915-6.
16. Starke JR, Correa AG: Management of mycobacterial infection and disease in children. Pediatr Infect Dis J 1995; 14: 455-69; 69-70.
17. Carrol ED, Clark JE, Cant AJ: Non-pulmonary tuberculosis. Paediatr Respir Rev 2001; 2: 113-9.
18. Schaaf HS, Beyers N, Gie RP, Nel ED, Smuts NA, Scott FE: Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations. Pediatr Infect Dis J 1995; 14: 189-94.
19. Olivier C, de Paillerets F: Tuberculose pulmonaire et primo-infection chez l'enfant. Etude rétrospective de 53 enfants. Presse Med 1987; 16: 889-93.
20. Toppet M, Malfroot A, Hofman B, Casimir G, Cantraine F, Dab I: Tuberculosis in children: a 13-year follow up of 1714 patients in a Belgian home care centre. Eur J Pediatr 1991; 150: 331-5.
21. Fox TG: Occult tuberculous infection in children. Tubercle 1977; 58: 91-6.
22. Gomez-Pastrana D, Torronteras R, Caro P, Anguita ML, Barrio AM, Andres A: Diagnosis of tuberculosis in children using a polymerase chain reaction. Pediatr Pulmonol 1999; 28: 344-51.
23. Delacourt C, Poveda JD, Chureau C, Beydon N, Mahur B, de Blic J: Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J Pediatr 1995; 126: 703-9.
24. Fauville-Dufaux M, Waelbroeck A, De Mol P, Vanfleteren B, Levy J, Debusschere P: Contribution of the polymerase chain reaction to the diagnosis of tuberculous infections in children. Eur J Pediatr 1996; 155: 106-11.
25. Delacourt C, Mani TM, Bonnerot V, de Blic J, Sayeg N, Lallemand D: Computed tomography with normal chest radiograph in tuberculous infection. Arch Dis Child 1993; 69: 430-2.
26. Kim WS, Moon WK, Kim IO, Lee HJ, Im JG, Yeon KM: Pulmonary tuberculosis in children: evaluation with CT. Am J Roentgenol 1997; 168: 1005-9.
27. Neu N, Saiman L, San Gabriel P, Whittier S, Knirsch C, Ruzal-Shapiro C: Diagnosis of pediatric tuberculosis in the modern era. Pediatr Infect Dis J 1999; 18: 122-6.
28. Wong KS, Huang YC, Lin TY: Radiographic presentation of pulmonary tuberculosis in young children. Acta Paediatr Taiwan 1999; 40: 171-5.
29. Leung AN, Muller NL, Pineda PR, FitzGerald JM: Primary tuberculosis in childhood: radiographic manifestations. Radiology 1992; 182: 87-91.
30. Madhi F, Fuhrman C, Monnet I, Atassi K, Poirier C, Housset B: Transmission of tuberculosis from adults to children in a Paris suburb. Pediatr Pulmonol 2002; 34: 159-63.
31. Al-Marri MR, Kirkpatrick MB: Erythrocyte sedimentation rate in childhood tuberculosis: is it still worthwhile? Int J Tuberc Lung Dis 2000; 4: 237-9.
32. Chiang IH, Suo J, Bai KJ, Lin TP, Luh KT, Yu CJ: Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med 1997; 156: 906-11.
33. Delacourt C, Gobin J, Gaillard JL, de Blic J, Veron M, Scheinmann P: Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children. Chest 1993; 104: 393-8.
34. Caminero JA, Rodriguez de Castro F, Carrillo T, Lafarga B, Daiz F, Cabrera P: Value of ELISA using A60 antigen in the serodiagnosis of tuberculosis. Respiration 1994; 61: 283-6.
35. Turneer M, Van Nerom E, Nyabenda J, Waelbroeck A, Duvivier A, Topper M: Determination of humoral immunoglobulins M and G directed against mycobacterial antigen 60 failed to diagnose primary tuberculosis and mycobacterial adenitis in children. Am J Respir Crit Care Med 1994; 150: 1508-12.
36. Imaz MS, Comini MA, Zerbini E, Sequeira MD, Spoletti MJ, Etchart AA: Evaluation of the diagnostic value of measuring IgG, IgM and IgA antibodies to the recombinant 16-kilodalton antigen of Mycobacterium tuberculosis in childhood tuberculosis. Int J Tuberc Lung Dis 2001; 5: 1036-43.
37. Mazurek GH, Villarino ME: Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 15-8.
38. Inokuchi N, Sugahara K, Soda H, Usui T, Hirakata Y, Fukushima K: Relationship between whole-blood interferon-gamma production and extent of radiographic disease in patients with pulmonary tuberculosis. Diagn Microbiol Infect Dis 2003; 46: 109-14.
39. Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW: Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002; 34: 1449-56.
40. Ewet K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet2003; 361: 1168-73.
41. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ: Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-21.
42. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM: Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000:CD001363.
43. Chaulet P, Mazouni M: Les médicaments de la tuberculose chez l'enfant. Effets indésirables et surveillance du traitement. In: Pons G, Gendrel D, Grosset J, Eds. Les médicaments de la tuberculose chez l'enfant. Springer-Verlag, Paris. 1998: 131-57.
44. Nolan CM, Goldberg SV, Buskin SE: Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014-8.
45. Sanchez-Albisua I, Vidal ML, Joya-Verde G, del Castillo F, de Jose MI, Garcia-Hortelano J: Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children. Pediatr Infect Dis J 1997; 16: 760-3.
46. Centers for Disease Control and Prevention: Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection. JAMA 2002; 288: 2967.
47. Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E: Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 2002; 137: 640-7.
48. McNeill L, Allen M, Estrada C, Cook P: Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Chest 2003; 123: 102-6.
49. Stout JE, Engemann JJ, Cheng AC, Fortenberry ER, Hamilton CD: Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis. Am J Respir Crit Care Med 2003; 167: 824-7.
50. American Thoracic Society, Centers for Disease Control and Prevention, America 1DSo: Treatment of tuberculosis. Am J Respir Crit Care Med2003; 167: 603-62.
51. Eidlitz-Markus T, Zeharia A, Baum G, Mimouni M, Amir J: Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest 2003; 123: 736-9.
52. Decludt B, Campese C, Institut de Veille Sanitaire: Les cas de tuberculose déclarés en France en 2000. Bulletin épidémiologique hebdomadaire 2002; 16-17: 68-70.
53. Correa AG: Unique aspects of tuberculosis in the pediatric population. Clin Chest Med 1997; 18: 89-98.
54. Dubus JC, Piarroux R, Panuel M, Garnier JM, Faure F, Devred P: Tuberculose pulmonaire de l'enfant. A propos de 6 cas. Arch Pediatr 1994; 1: 782-6.
55. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E: The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96: 29-35.
56. Chee CB, Soh CH, Boudville IC, Chor SS, Wang YT: Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001; 164: 958-61.
57. Citron K: Tuberculin positive children. Thorax 1992; 47: 768-9.
58. Lobam MN, Hopewell PC: Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998; 158: 1871-5.
59. Saiman L, San Gabriel P, Schulte J, Vargas MP, Kenyon T, Onorato I: Risk factors for latent tuberculosis infection among children in New York City. Pediatrics 2001; 107: 999-1003.
60. Bailey WC, Gerald LB, Kimerling ME, Redden D, Brook N, Bruce F: Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 2002; 287: 996-1002.
61. Joint Tuberculosis Committee of the British Thoracic Society: Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax2000; 55: 887-901.
62. Gessner BD, Weiss NS, Nolan CM: Risk factors for pediatric tuberculosis infection and disease after household exposure to adult index cases in Alaska. J Pediatr 1998; 132: 509-13.
63. Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20: 581-620.
64. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV: Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-4.
65. Beyers N, Gie RP, Schaaf HS, Van Zyl S, Talent JM, Nel ED: A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 38-43.
66. Almeida LM, Barbieri MA, Da Paixao AC, Cuevas LE: Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001; 20: 1061-5.
67. Lobato MN, Mohle-Boetani JC, Royce SE: Missed opportunities for preventing tuberculosis among children younger than five years of age. Pediatrics 2000; 106: E75.
68. Ildirim I, Hacimustafaoglu M, Ediz B: Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr Infect Dis J 1995; 14: 1060-3.
69. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM: A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-9.